Zoetis Inc.

Pharmaceutical Preparations·PARSIPPANY, NJ·FY end 12/31·CIK 1555280

Overview Financials Compensation Governance Insiders Filings

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Jamie Brannan	—	—	—	—	—	—
Kristin C. PeckChief Executive Officer	$1.4M	$3.4M	$2.2M	$12.1M	$19.0M	—
Robert J. PolzerFormer EVP and President of Research and Development	$710.0K	$555.5K	$590.7K	$1.8M	$3.7M	—
Robert PolzerEVP and President, Research and Development	—	—	—	—	—	—
Roxanne LaganoEVP, General Counsel and Corporate Secretary	$700.0K	$347.5K	$604.8K	$1.2M	$2.8M	—
Wetteny JosephExecutive Vice President (“EVP”) and Chief Financial Officer	$800.0K	$950.0K	$832.0K	$3.0M	$5.6M	—

CEO pay mix

Kristin C. Peck · FY 2025

Stock awards$3.4M9%

Performance bonus$12.1M32%

Salary$1.4M4%

Other$21.2M56%

Performance vs. pay

Item 402(v) Pay-Versus-Performance disclosure data not yet ingested for this company. Mandatory only for FYs ending on/after Dec 16, 2022 — older companies may not have filed it yet.

CEO comp · median worker · ratio — multi-year trend

Need at least two fiscal years of proxy data to draw the trend line. The ingestion worker will populate prior-year proxies as it processes them.